Author Archive

Medilink EM Podcast : FDA Approval

| October 10, 2011 | 0 Comments

FDA Registration podcast featuring Pete Rose and Lee Simpson from High Edge Consulting and Carl Barrett from Monica Healthcare in discussion with Louise Third [Audio clip: view full post to listen]  

Filed Under: Podcasts

Volatile international IPO activity highlights need to cut red tape for SMEs

| October 7, 2011 | 0 Comments

Structural reforms are needed to make the IPO market more attractive to small and medium-sized enterprises (SMEs) in the wake of considerable volatility across European Exchanges since 2000, according to a new report published by the City of London Corporation today.

Filed Under: Colin Mason

William Hill Building Contractors appoint new Managing Director

| September 29, 2011 | 0 Comments

Owners Andrew Hill and David Stone, have appointed Paul Martin as the Company Managing Director of Colwick based construction company William Hill Building Contractors. Mr. Paul Martin (48) from the Vale of Belvoir has worked with the firm since 2007 as Contracts Manager then General Manager and in his new role will oversee the company’s continuing expansion in Nottingham, the East Midlands and the Home Counties.

Filed Under: William Hill Builders

Cancer charity to benefit from East Midlands Art Awards

| September 14, 2011 | 0 Comments

Winner of the 2010 Healthcare and BioScience iNet Art Award Martin Bonney has donated his award-winning creation to Marie Curie Cancer Care to mark the launch of the 2012 iNet art competition, ‘Where Art Meets Science’.

Sygnature Chemical Services becomes Sygnature Discovery to better reflect its Integrated Drug Discovery Service-Offering

| September 13, 2011 | 0 Comments

Nottingham, UK – 13th September 2011 – Sygnature Chemical Services, a leading provider of drug discovery services to the pharmaceutical industry, has today become Sygnature Discovery. Due to an unprecedented demand for Sygnature’s services from clients in the USA and Europe over the past 12 months and the addition of bioscience to its in-house capabilities, Sygnature has been renamed Sygnature Discovery to better reflect the portfolio of integrated drug discovery services that it now offers.

Filed Under: Sygnature Discovery

Student with Edwards wins National Award

| September 13, 2011 | 0 Comments

Jonathan Wilde, a gap year student working at global vacuum and abatement engineering company Edwards has taken maximum advantage of his time before university by scooping the top national prize in “The Year in Industry”, the leading working gap year programme for students working in science, technology, engineering and maths, run by education charity EDT.

Filed Under: EDT National

BioCity hatches new life with AstraZeneca experts

| September 13, 2011 | 0 Comments

Six brand new companies started by former AstraZeneca Charnwood employees will create a total of 15 jobs within BioCity Nottingham by the end of November this year.

Filed Under: BioCity Nottingham

Integra Communications Podcast Samples

| September 9, 2011 | 0 Comments

The recordings below are samples of podcast recordings made by Integra Communications on behalf of various clients. To find out more about recording podcasts through Integra Communications contact Louise Third on 0115 912 4350 The First Podcast is an introduction to the subject of podcasts in the company of Costa Philippou, Marketing Manager of Medilink [...]

Response to the Research from Birmingham University on Employment of Science and Engineering Graduates

| September 8, 2011 | 0 Comments

Dr Gordon Mizner, Chief Executive of EDT

Filed Under: EDT National

Seal of approval for Pepceuticals

| August 31, 2011 | 0 Comments

UK pharmaceutical manufacturer, Pepceuticals, has been given MHRA approval for the manufacture of APIs following an additional £2 million investment in new premises and state-of-the-art manufacturing facilities in Leicestershire, UK. Pepceuticals is now the largest peptide cGMP manufacturer in mainland UK and is the Research Council UK (RCUK) preferred supplier of peptides and antibodies.

Filed Under: Pepceuticals